Rhythm Pharmaceuticals (RYTM) Total Debt (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Total Debt of $108.5 million for Q1 2026, down 0.96% year-over-year from $109.5 million in Q1 2025, and little changed quarter-over-quarter from $108.2 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Total Debt (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 6 years of Total Debt data on file, last reported at $108.5 million in Q1 2026.
- Total Debt for Q1 2026 came in at $108.5 million, down 0.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.5 million (down 0.96% YoY), and the FY2025 annual result was $108.2 million, down 1.48% from the prior year.
- Total Debt steadied at $108.5 million in Q1 2026 per RYTM's latest filing, from $108.2 million in the prior quarter.
- Over five years, Total Debt peaked at $109.8 million in Q4 2024 and troughed at $106.1 million in Q4 2023.
- A 4-year average of $108.7 million and a median of $109.0 million in 2025 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt climbed 3.45% in 2024, then declined 1.48% in 2025.
- A 4-year view of Total Debt shows it stood at $106.1 million in 2023, then climbed by 3.45% to $109.8 million in 2024, then slipped by 1.48% to $108.2 million in 2025, then advanced by 0.27% to $108.5 million in 2026.
- Business Quant data shows RYTM's Total Debt at $108.5 million in Q1 2026, $108.2 million in Q4 2025, and $109.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 108.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.47 Mn |
| Dec 31, 2025 | 108.18 Mn |
| Sep 30, 2025 | 108.97 Mn |
| Jun 30, 2025 | 109.79 Mn |
| Mar 31, 2025 | 109.52 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Dec 31, 2023 | 106.14 Mn |
| Dec 31, 2017 | 90,000.00 |
| Sep 30, 2017 | 130,000.00 |
| Dec 31, 2016 | 155,000.00 |